Back to discover

Drug

Pyruvaldehyde

Research stage

Emerging research

Also known as Methyl glyoxal.

RxNorm1373350 ChEMBLCHEMBL170721UNII722KLD7415

1

Research papers

Latest activity

beta

Recent clinical, regulatory, research and industry developments relating to this drug.

Methylglyoxal-induced neurotoxic effects in primary neuronal-like cells transdifferentiated from human mesenchymal stem cells: Impact of low concentrations.

Research2023-07-10Journal of applied toxicology : JAT

Profile

Identifiers & mechanism

Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.

Canonical name

Pyruvaldehyde

Aliases & brands

Methyl glyoxal

RxNorm CUI

1373350

ChEMBL ID

CHEMBL170721

UNII

722KLD7415

Research activity

1 papers

Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.

Most influential

Methylglyoxal-induced neurotoxic effects in primary neuronal-like cells transdifferentiated from human mesenchymal stem cells: Impact of low concentrations.

Journal of applied toxicology : JAT · 2023 · 12 cites

Recent papers

Methylglyoxal-induced neurotoxic effects in primary neuronal-like cells transdifferentiated from human mesenchymal stem cells: Impact of low concentrations.

Journal of applied toxicology : JAT · 2023 · 12 cites

Major research themes3

Mesenchymal Stem Cells1Neuroblastoma1Neurotoxicity Syndromes1

Journals, researchers & institutions

Top journals

Journal of applied toxicology : JAT1

Leading researchers

Caloni F1
Coccini T1
De Simone U1
Grignani E1
Locatelli CA1
Negri S1
Schicchi A1

Leading institutions

free-text, unnormalised

Environmental Research Center1
Laboratory of Clinical and Experimental Toxicology1
Università degli Studi di Milano1

References & data sources

RxNorm (U.S. National Library of Medicine) — drug identity
ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
Europe PMC — research literature